Abstract
Objective:
The Oslo Diet and Antismoking study was a 5-year randomised trial initiated in 1972–1973, which studied the effect of dietary change and smoking cessation for the prevention of coronary heart disease among high-risk middle-aged men. To test the long-term maintenance of lifestyle change, we examined diet and cardiovascular risk factors in subjects initially randomised to the control and intervention groups 20 years after cessation of the intervention.
Subjects and design:
Of the original cohort that included 1232 participants, 910 survivors were identified in 1997 and cardiovascular risk factors were measured in 563 (62%) in 1997–1999. Of these, 558 (99%) also completed questionnaires about their food intake and attitudes to health and diet.
Results:
Cigarette smoking was nearly halved between baseline and 20-year follow-up in each of the intervention and control groups (P<0.001 within groups), but did not differ between the intervention group (39%) versus the control group (34%); P=0.07. Body mass index increased by 1.4±2.6 and 1.6±2.6 kg/m2 between baseline and 20-year follow-up in the intervention and control groups, respectively (P<0.001 within groups; NS between groups). Serum total cholesterol and triglyceride concentrations decreased substantially in subjects treated or untreated with statins (P<0.001 within the intervention and control groups) but did not differ between the groups (total cholesterol change of −1.4±1.3 and −1.3±1.2 mmol/l, respectively, and triglyceride change of −0.5±1.0 mmol/l in both groups). Men in the intervention group reported a less atherogenic fat quality score and lower intakes of fat, saturated fat and cholesterol, higher intakes of long chain polyunsaturated fatty acids, protein and beta-carotene and greater attention to lifestyle and change of diet than the control group (all P<0.05). The fatty acid concentrations did not differ, however, between the intervention and control groups (P>0.05).
Conclusions:
No long-term differences in smoking rates or lipid concentrations between the intervention and control groups were observed in the surviving attendees two decades after the end of the trial. Lifestyle intervention still influenced the dietary intake, though modestly.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Andersen LF, Solvoll K, Drevon CA (1996). Very-long chain n-3 biomarkers for intake of fish and n-3 fatty acids concentrates. Am J Clin Nutr 64, 305–311.
Andersen LF, Solvoll K, Johansson LRK, Salminen I, Aro A, Drevon CA (1999). Evaluation of a food frequency questionnaire with weighted records, fatty acids and alpha-tocopherol in adipose tissue and serum. Am J Epidemiol 150, 75–87.
Connor WE, Connor SL (2002). Dietary cholesterol and coronary heart disease. Curr Atheroscler Rep 4, 425–432.
Cutler JA, Grandits GA, Grimm Jr RH, Thomas Jr HE, Billings JH, Wright NH (1991). Risk factor changes after cessation of intervention in the Multiple Risk Factor Intervention Trial. Prev Med 20, 183–196.
Dallongeville J, Marecaux N, Fruchart JC, Amouyel P (1998). Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis. J Nutr 128, 1450–1457.
Dattilo AM, Kris-Etherton PM (1992). Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 56, 320–328.
de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaund I et al. (1994). Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343, 1454–1459.
Eliasson B, Attvall S, Taskinen MR, Smith U (1997). Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest 27, 450–456.
Ellingsen I, Hjermann I, Abdelnoor M, Hjerkinn E, Tonstad S (2003). Dietary and antismoking advice and coronary heart disease mortality in men with usual or high fasting triacylglycerol concentrations. A 23-y follow-up study. Am J Clin Nutr 78, 935–940.
National Cholesterol Education Program (2001). Expert summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486–2497.
Gorder DD, Dolecek TA, Coleman GG, Tillotson JL, Brown HB, Lenz-Litzow K et al. (1986). Dietary intake in the Multiple Risk Factor Intervention Trial (MRFIT): nutrient and food group changes over 6 years. J Am Diet Assoc 86, 744–751.
Green MS, Harari G (1995). A prospective study of the effects of changes in smoking habits on blood count, serum lipids and lipoproteins, body weight and blood pressure in occupationally active men. The Israeli CORDIS Study. J Clin Epidemiol 48, 1159–1166.
Hjerkinn EM, Arnesen H, Hjermann I (2000). Diet and omega-3 fatty acid intervention trial on atherosclerosis (DOIT-study). Atherosclerosis 151, 145 (abstract).
Hjerkinn EM, Sandvik L, Hjermann I, Arnesen H (2004). Effect of diet intervention on long-term mortality in healthy middle-aged men with combined hyperlipidaemia. J Intern Med 255, 68–73.
Hjermann I (1981). Intervention of smoking and eating habits in healthy men carrying high risk for coronary heart disease. The Oslo Study (1981). Acta Med Scand Suppl 651, 281–284.
Hjermann I, Holme I, Velve BK, Leren P (1981). Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in health men. Lancet II, 1303–1310.
Hjermann I, Holme I, Leren P (1986). Oslo Study Diet and Antismoking Trial. Results after 102 months. Am J Med 80 (Suppl 2A), 7–11.
Holme I (1982). On the separation of the intervention effects of diet and antismoking advice on the incidence of major coronary events in coronary high risk men. The Oslo Study. J Oslo City Hosp 32, 31–54.
Holme I, Lund Håheim L, Tonstad S, Hjermann I : Effect of dietary and antismoking advice on the incidence of myocardial infarction: a 16-year follow-up of the Oslo Diet and antismoking study after its close. Nutr Metab Cardiovasc Dis, accepted for publication.
Hooper L, Summerbell CD, Higgins JPT, Thompson RL, Capps NE, Smith GD et al. (2001). Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ 322, 757–763.
Hu FB, Willett WC (2002). Optimal diets for prevention of coronary heart disease. JAMA 288, 2569–2578.
Kristal AR, White E, Shattuck AL, Curry S, Anderson GL, Fowler A et al. (1992). Long-term maintenance of a low-fat diet: durability of fat-related dietary habits in the Women's Health Trial. J Am Diet Assoc 92, 553–559.
Leren P (1966). The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Med Scand Suppl 466, 1–92.
Leren P, Askevold E-M, Foss OP, Frøili A, Grymyr D, Helgeland A et al. (1975). The Oslo Study: cardiovascular disease in middle-aged and young Oslo men. Acta Med Scand Suppl 588, 1–38.
McColl KA (1988). The sugar fat seesaw. BNF Bull 13, 114–119.
Midthjell K, Krüger Ø, Holmen J, Tverdal A, Claudi T, Bjørndal A et al. (1999). Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Troendelag Health Survey 1984–1986 and 1995–1997. Diabetes Care 22, 1813–1820.
Solvoll K (2000). Development, evaluation and application of a quantitative food frequency questionnaire for assessment of dietary habits. Thesis. Institute for Nutrition Research, University of Oslo, Oslo, Norway.
Tang JL, Armitage JM, Lancaster T, Silagy CA, Fowler GH, Neil HAW (1998). Intervention trials to lower blood total cholesterol in free-living subjects. BMJ 316, 1213–1219.
Statens Tobakkskaderåd (1994). Opp i røyk? Om tobakksbruk i Norge gjennom 20 år: 1973–93. Statens Tobakkskaderåd: Oslo, Norway.
Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (2003). European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 24, 1601–1610.
Wøien G, Øyen O, Graff-Iversen S (1997). 22 years of cardiovascular surveys in Norwegian counties. Is the development in risk factors satisfactory? Nor J Epidemiol 7, 255–266.
Acknowledgements
We thank Ingar Holme for helpful comments, Liv Breivik and Lise Bergengen for excellent administrative assistance, Paula Berstad for the fatty acid analyses and Kari Solvoll for assistance with the dietary analyses. This study was supported by the Norwegian Cardiovascular Council and by the Norwegian retail company RIMI.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guarantor: S Tonstad.
Contributors: IE: study design, data collection, statistics, writing the manuscript; IS: study design, data collection, data analysis, statistics; EMH: study design, data collection; HA: study design, data analysis, statistics; IH study design; ST: study design, data analysis, writing the manuscript, supervising IE.
Rights and permissions
About this article
Cite this article
Ellingsen, I., Hjerkinn, E., Arnesen, H. et al. Follow-up of diet and cardiovascular risk factors 20 years after cessation of intervention in the Oslo Diet and Antismoking Study. Eur J Clin Nutr 60, 378–385 (2006). https://doi.org/10.1038/sj.ejcn.1602327
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1602327
Keywords
This article is cited by
-
The long-term effect of screening and lifestyle counseling on changes in physical activity and diet: the Inter99 Study – a randomized controlled trial
International Journal of Behavioral Nutrition and Physical Activity (2015)